These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 32817205)

  • 1. COVID-19 and COPD.
    Leung JM; Niikura M; Yang CWT; Sin DD
    Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32817205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preterm birth: Potential risk factor for greater COVID-19 severity?
    Debevec T; Burtscher J; Millet GP
    Respir Physiol Neurobiol; 2020 Sep; 280():103484. PubMed ID: 32599161
    [No Abstract]   [Full Text] [Related]  

  • 3. [Smoking and coronavirus disease 2019 (COVID-19)].
    Underner M; Peiffer G; Perriot J; Jaafari N
    Rev Mal Respir; 2020 May; 37(5):433-436. PubMed ID: 32331829
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 and COPD: a narrative review of the basic science and clinical outcomes.
    Higham A; Mathioudakis A; Vestbo J; Singh D
    Eur Respir Rev; 2020 Dec; 29(158):. PubMed ID: 33153991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hearing loss and COVID-19: A note.
    Sriwijitalai W; Wiwanitkit V
    Am J Otolaryngol; 2020; 41(3):102473. PubMed ID: 32276732
    [No Abstract]   [Full Text] [Related]  

  • 6. Human recombinant soluble ACE2 in severe COVID-19.
    Zoufaly A; Poglitsch M; Aberle JH; Hoepler W; Seitz T; Traugott M; Grieb A; Pawelka E; Laferl H; Wenisch C; Neuhold S; Haider D; Stiasny K; Bergthaler A; Puchhammer-Stoeckl E; Mirazimi A; Montserrat N; Zhang H; Slutsky AS; Penninger JM
    Lancet Respir Med; 2020 Nov; 8(11):1154-1158. PubMed ID: 33131609
    [No Abstract]   [Full Text] [Related]  

  • 7. Does cystic fibrosis constitute an advantage in COVID-19 infection?
    Bezzerri V; Lucca F; Volpi S; Cipolli M
    Ital J Pediatr; 2020 Oct; 46(1):143. PubMed ID: 33023602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic Analysis Reveals Upregulation of ACE2 (Angiotensin-Converting Enzyme 2), the Putative SARS-CoV-2 Receptor in Pressure-but Not Volume-Overloaded Human Hearts.
    Stegbauer J; Kraus M; Nordmeyer S; Kirchner M; Ziehm M; Dommisch H; Kelle S; Kelm M; Baczko I; Landmesser U; Tschöpe C; Knosalla C; Falcke M; Schapranow MP; Regitz-Zagrosek V; Mertins P; Kuehne T
    Hypertension; 2020 Dec; 76(6):e41-e43. PubMed ID: 32969280
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical analysis of sinus bradycardia in patients with severe COVID-19 pneumonia.
    Hu L; Gong L; Jiang Z; Wang Q; Zou Y; Zhu L
    Crit Care; 2020 May; 24(1):257. PubMed ID: 32456695
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma levels of soluble ACE2are associated with sex, Metabolic Syndrome, and its biomarkers in a large cohort, pointing to a possible mechanism for increased severity in COVID-19.
    Kornilov SA; Lucas I; Jade K; Dai CL; Lovejoy JC; Magis AT
    Crit Care; 2020 Jul; 24(1):452. PubMed ID: 32698840
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular molecular mechanisms of disease with COVID-19.
    Foo R; Wang Y; Zimmermann WH; Backs J; Wang DW
    J Mol Cell Cardiol; 2020 Apr; 141():107. PubMed ID: 32289321
    [No Abstract]   [Full Text] [Related]  

  • 12. ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19.
    Pinto BGG; Oliveira AER; Singh Y; Jimenez L; Gonçalves ANA; Ogava RLT; Creighton R; Schatzmann Peron JP; Nakaya HI
    J Infect Dis; 2020 Jul; 222(4):556-563. PubMed ID: 32526012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease and the impact of COVID-19.
    Yoganathan A; Sajjad MS; Harky A
    J Card Surg; 2020 Aug; 35(8):2113. PubMed ID: 32542799
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetes mellitus: Lessons from the COVID-19 pandemic.
    Tousoulis D
    Hellenic J Cardiol; 2020; 61(1):1-2. PubMed ID: 32425483
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical Courses and Outcomes of Patients with Chronic Obstructive Pulmonary Disease During the COVID-19 Epidemic in Hubei, China.
    Hu W; Dong M; Xiong M; Zhao D; Zhao Y; Wang M; Wang T; Liu Z; Lu L; Hu K
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2237-2248. PubMed ID: 33061341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics and Outcomes of Patients with Severe COVID-19 and Chronic Obstructive Pulmonary Disease (COPD).
    He Y; Xie M; Zhao J; Liu X
    Med Sci Monit; 2020 Sep; 26():e927212. PubMed ID: 32883943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute peritoneal dialysis in COVID-19.
    Parapiboon W; Ponce D; Cullis B
    Perit Dial Int; 2020 Jul; 40(4):359-362. PubMed ID: 32552550
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19, chronic inflammatory respiratory diseases and eosinophils-Observations from reported clinical case series.
    Jesenak M; Banovcin P; Diamant Z
    Allergy; 2020 Jul; 75(7):1819-1822. PubMed ID: 32369190
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19.
    Diaz JH
    J Travel Med; 2020 May; 27(3):. PubMed ID: 32186711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence.
    Turgeon RD; Zieroth S; Bewick D; Chow CM; Clarke B; Cowan S; Fordyce CB; Fournier A; Gin K; Gupta A; Hardiman S; Jackson S; Lau B; Leong-Poi H; Mansour S; Marelli A; Quraishi AR; Roifman I; Ruel M; Sapp J; Singh G; Small G; Virani S; Wood DA; Krahn A
    Can J Cardiol; 2020 Aug; 36(8):1180-1182. PubMed ID: 32502522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.